(Q48002979)

7 February 2018

title

MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide (English)

1 reference

7 February 2018

0 references

1 reference

5

Giampietro Corradin

1 reference

7 February 2018

Christopher W. Schmidt

object named as

Christopher William Schmidt

4

0 references

author name string

Sandro Prato

1

1 reference

7 February 2018

Tammy Maxwell

2

1 reference

7 February 2018

Alberto Pinzón-Charry

3

1 reference

7 February 2018

José Alejandro López

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2005

1 reference

7 February 2018

European Journal of Immunology

published in

1 reference

7 February 2018

volume

35

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

681-689

1 reference

7 February 2018

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Synthetic peptide vaccine confers protection against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Mechanisms of MHC class I--restricted antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Clathrin-coated vesicle formation and protein sorting: an integrated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Caveolin, a protein component of caveolae membrane coats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Phagosomes are competent organelles for antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Extracellular processing and presentation of a 69-mer synthetic polypeptide to MHC class I-restricted T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425771

7 January 2021

Identifiers

DOI

10.1002/EJI.200425771

1 reference

7 February 2018

1 reference

7 February 2018